COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 670G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE1 DIABETES IN THE NETHERLANDS

E. Serne; S. Roze; M. I. Buompensiere; H. De Valk

COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 670G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE1 DIABETES IN THE NETHERLANDS

E. Serne, S. Roze, M. I. Buompensiere, H. De Valk

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	A15-A16
Journal	Diabetes Technology and Therapeutics
Volume	23
Publication status	Published - 1 Jun 2021

Cite this

@article{91587f20cdef41c6aafde1728d7f151e,

title = "COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 670G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE1 DIABETES IN THE NETHERLANDS",

author = "E. Serne and S. Roze and Buompensiere, {M. I.} and {De Valk}, H.",

year = "2021",

month = jun,

day = "1",

language = "English",

volume = "23",

pages = "A15--A16",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

}

COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 670G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE1 DIABETES IN THE NETHERLANDS. / Serne, E.; Roze, S.; Buompensiere, M. I. et al.
In: Diabetes Technology and Therapeutics, Vol. 23, 01.06.2021, p. A15-A16.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 670G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE1 DIABETES IN THE NETHERLANDS

AU - Serne, E.

AU - Roze, S.

AU - Buompensiere, M. I.

AU - De Valk, H.

PY - 2021/6/1

Y1 - 2021/6/1

M3 - Meeting Abstract

SN - 1520-9156

VL - 23

SP - A15-A16

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

ER -